EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

IGFBP5 Restores Endometrial Receptivity and Rescues Implantation Failure in Polycystic Ovary Syndrome

Baoying Liao, Chuyu Yun, Hongying Shan, Yuqian Wang, Xiunan Chen, Weisi Lian, Tianliu Peng, Min Zhao, Xunsi Qin, Kailun Hu, Ping Zhou, Yue Wang und 2 weitere

Advanced Science · 2026

DOI: 10.1002/advs.202520455 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Baoying Liao und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Female Fertility Promotion, Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Thir…. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Endometrium, Embryo Implantation, Insulin-Like Growth Factor Binding Protein 5. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Scientific Research Innovation Capability Support Project for Young Faculty.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polycystic ovary syndrome (PCOS) is a metabolic disorder and a major cause of infertility, affecting approximately 5–18% of women of reproductive age worldwide. Emerging evidence suggests that intrinsic endometrial defects play a critical role in PCOS‐associated infertility; however, the underlying molecular mechanisms remain poorly understood. In this study, we demonstrated that interleukin 22 (IL‐22) signaling directly modulated endometrial function and that downregulation of the IL‐22‐STAT3 pathway contributed to impaired endometrial receptivity in PCOS. Consistently, exogenous IL‐22 administration in a PCOS‐like mouse model restored STAT3 phosphorylation and effectively alleviated implantation failure by enhancing endometrial receptivity. Mechanistically, we identified insulin‐like growth factor‐binding protein 5 (IGFBP5) as a direct downstream target of STAT3 in endometrial organoids derived from patients with PCOS. Knockdown of IGFBP5 in the uteri of PCOS‐like mice abolished the beneficial effects of IL‐22, whereas IGFBP5 supplementation restored endometrial receptivity and rescued implantation. Collectively, we showed that the suppression of the IL‐22‐STAT3‐IGFBP5 axis is a key contributor to impaired endometrial receptivity in PCOS, providing a potential therapeutic target for improving pregnancy outcomes via IGFBP5 supplementation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeEndometriumEmbryo ImplantationInsulin-Like Growth Factor Binding Protein 5Infertility, FemaleFemaleAnimalsMiceHumansInterleukinsSTAT3 Transcription FactorDisease Models, AnimalInterleukin-22Signal Transduction

Stichwörter der Autor:innen

IGFBP5IL‐22‐STAT3 signaling pathwayendometrial organoidsendometrial receptivitypolycystic ovary syndrome

Substanzen

InterleukinsInsulin-Like Growth Factor Binding Protein 5STAT3 Transcription FactorInterleukin-22

Autor:innen und Institutionen

  • State Key Laboratory of Female Fertility Promotion, Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, National Clinical Research Center for Obstetrics and Gynec…
  • Reproductive Medicine Department, The First Affiliated Hospital of Shihezi University, Shihezi, China.
  • Center for Precision Medicine Multi-Omics Research, Institute of Advanced Clinical Medicine, Peking University, Beijing, China.
  • Beijing Advanced Center of Cellular Homeostasis and Aging-Related Diseases, Institute of Advanced Clinical Medicine, Peking University, Beijing, China.

ORCID-Profile: Rong Li

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Scientific Research Innovation Capability Support Project for Young Faculty
  • Xinjiang Production and Construction Corps Guiding Science and Technology Program
  • Excellent Doctoral Innovation Fund of Peking University Health Science Center

Zitieren

APA

Liao, B., Yun, C., Shan, H., Wang, Y., Chen, X., Lian, W., Peng, T., Zhao, M., Qin, X., Hu, K., Zhou, P., Wang, Y., Pang, Y., & Li, R. (2026). IGFBP5 Restores Endometrial Receptivity and Rescues Implantation Failure in Polycystic Ovary Syndrome. Advanced Science. https://doi.org/10.1002/advs.202520455

Vancouver

Liao B, Yun C, Shan H, Wang Y, Chen X, Lian W, et al. IGFBP5 Restores Endometrial Receptivity and Rescues Implantation Failure in Polycystic Ovary Syndrome. Advanced Science. 2026. doi:10.1002/advs.202520455

BibTeX
@article{Liao2026,
  author = {Liao, Baoying and Yun, Chuyu and Shan, Hongying and Wang, Yuqian and Chen, Xiunan and Lian, Weisi and Peng, Tianliu and Zhao, Min and Qin, Xunsi and Hu, Kailun and Zhou, Ping and Wang, Yue and Pang, Yanli and Li, Rong},
  title = {IGFBP5 Restores Endometrial Receptivity and Rescues Implantation Failure in Polycystic Ovary Syndrome},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202520455}
}
Kostenlos starten →